Products
EarlyTect BCD | Promis Diagnostics
Product description
EarlyTect BCD is a urine-based test designed for the early detection of bladder cancer. It utilizes our patented LTE-qMSP technology to identify methylated DNA biomarkers indicative of bladder cancer, offering a convenient and accurate screening option.